StockData
Veracyte, Inc. logo

Veracyte, Inc. (VCYT) stock

VCYTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3029% below fair value
$25.57+1.34 (+5.53%)

Close on Nov 18, 2026Market cap $2.06BP/E 18.3Yield –

Veracyte total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Veracyte's total debt was $0 at Dec 31, 2022. For fiscal 2022 it was $0, down 100.0% from the year before. The highest annual figure on record is $25.28M in fiscal 2018.

Annual total debt

PeriodPeriod endValueChange
FY2022Dec 31, 2022$0-100.0%
FY2021Dec 31, 2021$1.13M+39.1%
FY2020Dec 31, 2020$810.00K+16.7%
FY2019Dec 31, 2019$694.00K-97.3%
FY2018Dec 31, 2018$25.28M+1.4%
FY2017Dec 31, 2017$24.94M+0.1%
FY2016Dec 31, 2016$24.92M+399.4%
FY2015Dec 31, 2015$4.99M+1.4%
FY2014Dec 31, 2014$4.92M+0.5%
FY2013Dec 31, 2013$4.90M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022$0-100.0%
Q3 FY2022Sep 30, 2022$1.19M+10.4%
Q2 FY2022Jun 30, 2022$1.13M+23.6%
Q1 FY2022Mar 31, 2022$1.08M+25.0%
Q4 FY2021Dec 31, 2021$1.13M+39.1%
Q3 FY2021Sep 30, 2021$1.08M+42.2%
Q2 FY2021Jun 30, 2021$917.00K+14.5%
Q1 FY2021Mar 31, 2021$863.00K+15.4%
Q4 FY2020Dec 31, 2020$810.00K+16.7%
Q3 FY2020Sep 30, 2020$756.00K+18.3%
Q2 FY2020Jun 30, 2020$801.00K+36.9%
Q1 FY2020Mar 31, 2020$748.00K-94.2%
Q4 FY2019Dec 31, 2019$694.00K-97.3%
Q3 FY2019Sep 30, 2019$639.00K-97.5%
Q2 FY2019Jun 30, 2019$585.00K-97.7%
Q1 FY2019Mar 31, 2019$12.85M-48.6%
Q4 FY2018Dec 31, 2018$25.28M+1.4%
Q3 FY2018Sep 30, 2018$25.19M+0.8%
Q2 FY2018Jun 30, 2018$25.10M+0.5%
Q1 FY2018Mar 31, 2018$25.02M+0.3%
Q4 FY2017Dec 31, 2017$24.94M+0.1%
Q3 FY2017Sep 30, 2017$25.00M+0.4%
Q2 FY2017Jun 30, 2017$24.97M–
Q1 FY2017Mar 31, 2017$24.94M–
Q4 FY2016Dec 31, 2016$24.92M–
Q3 FY2016Sep 30, 2016$24.89M–

More Veracyte figures

See a number that looks wrong?